EUVIMEDEUVIMED entdecken
Open Access

Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria

Samson E Isa, Attah Okwute, Kelly O Iraoyah, Shehu Y Nathan, Gomerep S Simji, Mark O Okolo, Joseph Anejo-Okopi, Daria Spicola, Daisy E Isa

Nigerian Medical Journal · 2016-07 · 57 (4) · 246-250

DOI: 10.4103/0300-1652.188362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nigerian Medical Journal, 2016-07. Verfasst von Samson E Isa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Infectious Diseases Unit, University of Jos/Jos University Teaching Hospital, Jos, Plateau State, Nigeria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Secondary transmission of Lassa fever (LF) occurs in the community and in health-care facilities, and is associated with high fatality in Nigeria. We investigated the role of oral ribavirin postexposure prophylaxis (orPEP) in preventing LF among the primary contacts of confirmed cases from December 2015 to March 2016. Materials and Methods: Epidemiological and clinical data of LF contacts were prospectively collected. However, information regarding ribavirin adverse effects (AEs) were collected retrospectively through a telephone interview. High-risk contacts were clinically monitored ΁ orPEP.

Results

Thirty-five (94.6%) out of the 37 individuals enrolled in the study were contacts of confirmed LF cases, and friends and family members (54%) constituted the largest group. However, only 29 (83%) individuals were classified as high-risk contacts. Twenty-one (60%) of contacts were prescribed ribavirin with 6 (28.6%) of them reporting AEs. Body weakness (33%) was the most frequent AE, but there was no incidence of treatment discontinuation due to AE. Furthermore, there were no reported cases of LF among all respondents (0%), whether they had orPEP or not.

Conclusion

Secondary transmission of LF seems uncommon and the benefit of orPEP is uncertain. Although AEs of ribavirin may not be uncommon, they are rarely serious enough to cause treatment interruption. More emphasis should be on supporting persons looking after LF cases adopt measures that minimize the risks of exposure.

Schlagwörter

Stichwörter der Autor:innen

Lassa feverNigeriaoral ribavirinprophylaxissecondary transmission

Autor:innen und Institutionen

  • Department of Medicine, Infectious Diseases Unit, University of Jos/Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
  • Department of Medical Microbiology, University of Jos/Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
  • Department of Microbiology, University of Jos, Jos, Plateau State, Nigeria.
  • Department of Internal Medicine, Infectious Diseases Unit, Arnas Civico Di Cristina Benfratelli, Palermo, Italy.
  • Department of Pharmaceutical Sciences, Aston University, Birmingham, United Kingdom.

Zitieren

APA

Isa, S. E., Okwute, A., Iraoyah, K. O., Nathan, S. Y., Simji, G. S., Okolo, M. O., Anejo-Okopi, J., Spicola, D., & Isa, D. E. (2016). Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria. Nigerian Medical Journal, 57(4), 246-250. https://doi.org/10.4103/0300-1652.188362

Vancouver

Isa SE, Okwute A, Iraoyah KO, Nathan SY, Simji GS, Okolo MO, et al. Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria. Nigerian Medical Journal. 2016;57(4):246-250. doi:10.4103/0300-1652.188362

BibTeX
@article{Isa2016,
  author = {Isa, Samson E and Okwute, Attah and Iraoyah, Kelly O and Nathan, Shehu Y and Simji, Gomerep S and Okolo, Mark O and Anejo-Okopi, Joseph and Spicola, Daria and Isa, Daisy E},
  title = {Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria},
  journal = {Nigerian Medical Journal},
  year = {2016},
  volume = {57},
  number = {4},
  pages = {246--250},
  doi = {10.4103/0300-1652.188362}
}
Kostenlos starten →